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Access to Catheterization Facilities in 
Patients Admitted With ST-elevation 
Myocardial Infarction
John A. Goudevenos, MD
The primary goal of therapy for acute ST-elevation myocardial infarction (STEMI) 
is rapid, complete and sustained restoration of the infarct related coronary artery 
blood flow and myocardial perfusion, with a consequent positive impact on the 
patient’s outcome. Timely reperfusion of the infarct-related artery is the cornerstone 
of therapy for this goal.
Thrombolytic therapy and percutaneous coronary intervention (PCI) are effective 
means to achieve reperfusion, but current trends reflect an increasing preference for 
PCI. Even though the development of reperfusion strategies and ancillary therapies 
over the last decades resulted in significant improvement in the prognosis of STEMI, 
the implementation of such therapies in the ‘real world’ is often inefficient. Despite 
the increasing use of primary PCI, the proportion of eligible patients undergoing early 
reperfusion remained constant at about 70%, from 1994 through 1999, with roughly 
30% of patients receiving neither reperfusion therapy. Findings from the GRACE study 
showed that nearly one –third of patients who presented with STEMI within 12 hours 
and who were eligible for reperfusion therapy did not receive it. Thus, a considerable 
proportion of patients with STEMI do not receive reperfusion therapy for a variety of 
reasons. These include age, gender, concomitant comorbid conditions, delays in seek-
ing medical attention, disparities in health system organization, ‘triaging’ problems, 
disparities in patients’ transfer, awareness of the public, and other reasons.
On the other hand, when primary PCI is available in a “timely” fashion and the 
procedure can be performed by an experienced operator in a large volume center, 
PCI should be considered the preferred reperfusion strategy. However, one of the 
biggest remaining problems is that this strategy is vastly underutilized. The majority 
of patients with STEMI are admitted to local hospitals without primary PCI facili-
ties. Access to early angiography is limited in most countries around the world and in 
many regions of the US. Data from recent registries have shown that approximately 
60% of patients with high risk acute coronary syndromes (ACS) undergo angiogra-
phy, of whom approximately 2/3 undergo revascularization (based on the anatomy). 
Furthermore, only about 40-45% of patients undergo angiography within the first 48 
hours after admission. 
The European Society of Cardiology (ESC) guidelines on PCI offer interventional 
cardiologists a guide to decision –making when choosing the optimal time course and 
type of intervention for patients presenting with STEMI, with the aim of maximizing 
patient outcome and reducing mortality (Figure 1). Of the two methods of reperfu-
sion therapy of STEMI, PCI is more difficult to implement but offers the best results 
when performed in an optimal setting.
According to current guidelines, reperfusion therapy should be commenced in 
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all patients presenting with STEMI within 12 hours after the 
onset of symptoms. For those presenting in a hospital without 
a PCI facility within 3 hours after the onset of symptoms, 
fibrinolysis is an acceptable option of reperfusion therapy. 
After 3 hours following onset of symptoms, primary PCI is 
strongly favoured by all guidelines. The strategy of choice 
for patients admitted more than 6 h after symptom onset is 
definitely emergency catheterization because many of them 
will probably receive more harm than good from fibrinolysis, 
especially if their chest pain has subsided. In such patients 
further delay due to transportation to another site seems to 
be justified because myocardial salvage is minimal in this 
late phase and the ultimate goal is sustained patency of the 
infarct related artery and risk assessment. If primary PCI is 
not available, patients admitted approximately 6-12 h after 
symptom onset who have ongoing chest pain and persistent 
ST segment elevation may also be considered for fibrinolysis 
as a last chance of reperfusion. There is no evidence that 
fibrinolysis offers any benefit after 12 hours, possibly because 
it does not restore artery patency. Early PCI is also optimal 
but, in contrast to thrombolysis, revascularization after 12 
hours with PCI may be of some benefit. Primary PCI is also 
preferred for patients presenting with cardiogenic shock and 
for those with contraindications to thrombolysis, regardless of 
the time from symptom onset. Moreover, in the case of failed 
thrombolysis, rescue PCI should be immediately performed. 
Even in the case of successful thrombolysis, if it is feasible, 
the patient should be transferred for post-thrombolysis PCI 
within the first 24 hours post-admission.
T H E  G R E E K  C O H O R T
There seems to be considerable international and national 
differences in the management of the STEMI population. 
Pertinent epidemiological data for Greece are lacking. Thus, 
the aim of our pilot study was to investigate the current imple-
mentation of these strategies in North-Western (NW) Greece, 
an isolated area with 600,000 inhabitants. The region is served 
by 6 General District Hospitals, and 1 Tertiary – University 
Hospital having cardiac catheterization laboratory with PCI 
facilities. Primary PCI can not be implemented as a routine 
treatment option in our region since there is no experienced 
staff on-call available on a 7-day/24-hour basis. Because the 
catheterization laboratory during daytime is busy with elec-
tive cases it is difficult to accommodate STEMI patients for 
primary PCI. For the time being only patients really in trouble 
and hypotensive, young with large infarcts or with contrain-
dication to fibrinolysis can undergo primary PCI, as there is 
no policy of prehospital thrombolysis or of facilitated PCI. 
Thus, the most prevalent reperfusion strategy in our region 
is thrombolytic therapy. 
The present study was a prospective population-based 
survey conducted over a 5-month period. Sources of data 
included cardiology departments, coronary care units, and 
intensive care departments located in the area. The total study 
population consisted of 170 consecutive patients (135 men, 35 
women). For all hospitals the current policy is to thrombolyse 
patients with STEMI and transfer only for rescue PCI. They 
were divided into three groups according to time between 
symptom onset and presentation to the hospital. Ninety nine 
patients (58.2%, 76 men, 23 women, mean age 62 years) 
presented to the admitting hospitals within 3 hours after the 
onset of symptoms, 23 (13.5%, 17 men, 6 women, mean age 
69.5 years) between 3 and 12 hours, and 48 (28.2%, 42 men, 
6 women, mean age 68.2 years) after 12 hours. 
In the first group of patients, thrombolysis was performed 
in 78 (78.7%), primary PCI in 8 (8%) and rescue PCI in 6 
(6%). Ninety three patients (94%) were subjected to elective 
coronary angiography and subsequently 38 (40.8%) of them 
to elective PCI, 4 (4.3%) to coronary artery bypass grafting 
(CABG), and 51 (54.8%) were managed conservatively. In 
the second group (3-12 hours), thrombolysis was performed 
in 17 (73.9%), and rescue PCI in 2 (8.6%) patients, while no 
patient was subjected to primary PCI. All patients (100%) were 
subjected to elective coronary angiography and subsequently 
10 (43.4%) of them to elective PCI, 1 (4.3%) to CABG, and 
12 (52.1%) were managed conservatively. Finally, in the third 
group (>12 h), thrombolysis was performed in 4 (8.3%), and 
FIGURE 1. Flow chart of the treatment strategy for patients 
with STEMI.
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rescue PCI in 1 (2.1%) patient, while no patient was subjected 
to primary PCI. Forty-two (87.5%) patients were subjected to 
elective coronary angiography and subsequently 11 (22.9%) 
of them to elective PCI, 8 (16.6%) to CABG, and 29 (60.4%) 
were managed conservatively.
Our preliminary results show that at first the main reason 
for no reperfusion was the delayed presentation (>12 hours) 
of a substantial number of patients. Second, the main objec-
tive to achieve at least 75% of reperfusion therapy within the 
shortest possible time following onset of symptoms had been 
reached. The vast majority of patients with STEMI presenting 
within 3 hours and less often within 12 hours after the onset 
of symptoms was offered a reperfusion treatment, mainly 
thrombolysis. The length of prehospital delay was inversely 
proportional to the receipt of fibrinolytic therapy, with over 
86% of patients who presented within 3 hours after the onset 
of symptoms receiving reperfusion therapy and just over 74% 
who presented between 3 and 12 h after symptom onset. There 
is of course significant room for improvement in patients who 
present between 3 and 12 hours with the option of performing 
more frequently primary PCI. Finally the current practice in 
our region is to refer almost all patients for elective coronary 
angiography in a relatively long time interval (usually 2-7 days 
post-admission). Subsequently, a considerable proportion of 
those patients are offered a revascularization treatment 
without having undergone non-invasive tests for myocardial 
ischemia. 
We conclude that a large proportion of patients arrive late, 
but reperfusion therapy is sufficiently implemented in NW 
Greece. The goal of 75% is certainly attainable. Organizing 
networks of reperfusion at regional level based on a clear 
common protocol, can help to improve the rate of reperfusion 
therapy. Special attention should be paid to next-day PCI after 
successful thrombolysis, since it has been proven efficacious. 
Public information campaigns should be considered, as most 
of the time delay between onset of symptoms and start of 
reperfusion therapy is the delay in patients seeking medical 
attention.
In Greece no special funding exists for primary angio-
plasty and thrombolysis in the hospital remains the standard 
treatment. Things may be about to change, however, even 
though such a service would require enormous reorganization 
of services and considerable additional investment. Patients 
with acute myocardial infarction would bypass their local 
hospitals and go to specialized centers providing a 24-hour 
angioplasty service. This proposal entails daunting logistical 
and financial challenges, and the prospect of large numbers 
of emergency procedures, many of them performed out of 
regular working hours, raises questions about the quality of 
such a service. 
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